10 - Are molecular markers and advanced neuro-imaging useful to predict and monitor response to treatments in grade 2 gliomas?

Date 22 March 2013
Event Trends in Central Nervous System Malignancies 2013
Session Management of Grade 2 and 3 Glioma
Topics Central Nervous System Malignancies
Translational Research
Presenter R. Soffietti